The genetic testing
industry, all in one place.
533+ companies, funding rounds, clinical trials, and breakthroughs — tracked daily for founders, investors, and researchers.
533+
Companies tracked
across 8 categories
$12B+
Funding tracked
in VC investment
39+
News published
industry articles
Every Sunday
Weekly digest
Genetic Testing Digest
Browse by category
View all 533 companies →Featured companies
Illumina
Research Tools
Illumina is the world's leading provider of DNA sequencing and array-based technologies, enabling breakthroughs in life science research, translational and consumer genomics, and molecular diagnostics.
Natera
Prenatal Testing
Natera is a global diagnostics company specializing in cell-free DNA testing for prenatal screening, oncology, and organ health, with its flagship Panorama NIPT test used in millions of pregnancies annually.
Recently added
Alithea Genomics
Genetic Testing ·
Arctic Therapeutics
Genetic Testing ·
Biotia
Genetic Testing ·
BostonGene
Genetic Testing ·
Colossal Biosciences
Genetic Testing ·
Deepcell
Genetic Testing ·
DName-iT NV
Genetic Testing ·
eGenesis
Genetic Testing ·
Funding spotlight
Alithea Genomics
Private
Arctic Therapeutics
Private
Biotia
Private
BostonGene
Private
Colossal Biosciences
Private
Deepcell
Private
Latest news
GRAIL's Galleri blood test, which screens for over 50 cancer types from a single blood draw, is advancing through a pivotal Medicare coverage pathway that could make it available to millions.
China-based AccurEdit has secured $75M to develop gene editing therapies demonstrating encouraging early-stage results.
Vietnam's Gene Solutions is pursuing a Hong Kong IPO to finance its regional expansion across Southeast Asia's fast-growing genomics market.
Regeneron has received FDA approval for the first neurosensory gene therapy, a landmark moment for genomic medicine and rare disease treatment.
The AI in genomics market is projected to hit $9.32 billion by 2030, driven by surging demand for precision medicine applications worldwide.
Every Sunday
The Genetic Testing Digest
Funding rounds, breakthroughs, and precision medicine insights — curated weekly for industry professionals.
Subscribe free →For companies
Reach genomics decision-makers
Premium listings, newsletter sponsorships, and featured placements.
View packages →News & insights
All articles →GRAIL's Galleri Multi-Cancer Early Detection Test Advances Toward Broader Medicare Coverage
GRAIL's Galleri blood test, which screens for over 50 cancer types from a single blood draw, is advancing through a pivotal Medicare coverage pathway that could make it available to millions.
2026-06-23
FundingAccurEdit Raises $75M to Advance Gene Editing Therapies Showing Early Clinical Promise
China-based AccurEdit has secured $75M to develop gene editing therapies demonstrating encouraging early-stage results.
2026-07-16
FundingGene Solutions Eyes Hong Kong IPO to Fuel Southeast Asian Genomics Expansion
Vietnam's Gene Solutions is pursuing a Hong Kong IPO to finance its regional expansion across Southeast Asia's fast-growing genomics market.
2026-07-15
533+
Companies
across 8 sectors
$12B+
VC Invested
tracked in our database
3×/week
News published
Mon · Wed · Fri
13+
Articles
in our archive
Companies by sector
16
Consumer
206
Clinical
24
Oncology
9
Pharmacogenomics
18
Prenatal
1
Ancestry
64
Research
25
Genetic
The Genetic Testing Digest
Funding rounds, product launches, research breakthroughs, and the best jobs — curated weekly for the genetic testing industry.
No spam. Unsubscribe anytime.